Gastroenterology Research and Practice / 2009 / Article / Tab 2

Clinical Study

Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life

Table 2

Sickness impact profile, SIP (0% Best).

( )1st year2nd year

BaselineWeek 13Week 26Week 52WashoutWeek 13Week 26Week 52P-value

TreatmentNoneGLP-2GLP-2GLP-2NoneGLP-2GLP-2 + Cholyl-sarcosineGLP-2
Overall
Body care and movement
Mobility
Ambulation
Physical Dimension
Emotional behaviour
Social interaction
Alertness behaviour
Communication
Psychosocial Dimension
Sleep and rest
Home management
Work
Recreation and pastimes
Eating
Independent Categories
QOL VAS-score, 0–9 cm, 9 cm best * * * * * * * 0.01

QOL VAS-score Quality of life Visual Analog Scale, * compared to baseline by Dunnett’s test, compared to baseline by chi-square, alternatively Fisher exact test.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.